WELCOME TO THE ADD-ASPIRIN WEBSITE

This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.           

Add-Aspirin is a large randomised clinical trial, which is taking place in the UK and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.

Congratulations to our top 5 recruiting centres:
1. University Hospitals Coventry & Warwickshire
2. Worcestershire Royal Hospital
3. Royal Marsden Hospitals
4. Bristol Haematology & Oncology Centre
5. Churchill Hospital, Oxford


*FOR GENERAL AND CLINICAL QUERIES, PLEASE CHECK OUR
FAQs*

NEWS

Add-Aspirin Opens in India!

The Add-Aspirin Team are delighted to announce that Tata Memorial Hospital in Mumbai, India is now open to recruitment as of 1st August 2017. This has been an ongoing collaboration between TMH and MRC CTU staff who have worked hard to make this a possibility for the trial.


Read more

Quick links for
NHS professionals


REGISTER A PARTICIPANT

To RANDOMISE a participant please call +44 (0)20 7670 4777

UNBLIND A PARTICIPANT

 

BREAST


We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here   

Top recruiters: Royal Marsden Hospitals, Worcestershire Royal Hospital, Addenbrookes, Churchill Hospital Oxford

PARTICIPANTS REGISTERED: 1540
PARTICIPANTS RANDOMISED: 1184   

COLON/RECTUM 


We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here 

Top recruiters: Bristol Haematology & Oncology Centre, Worcestershire Royal Hospital, St James 's University Hospital

PARTICIPANTS REGISTERED: 858
PARTICIPANTS RANDOMISED: 648

STOMACH/OESOPHAGUS 


We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here

Top recruiters: Leicester Royal Infirmary, The Christie, Manor Hospital

PARTICIPANTS REGISTERED: 94
PARTICIPANTS RANDOMISED: 76

PROSTATE


We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here    

Top recruiters: Bristol Haematology & Oncology Centre, UCHW, University Hospital of Wales
                                             PARTICIPANTS REGISTERED: 685
PARTICIPANTS RANDOMISED: 516
     

The trial is being jointly funded by Cancer Research UK (grant number C471 /A15015, www.cancerresearchuk.org), the National Institute for Health Research Health Technology Assessment Programme (project number 12/01/38, www.nihr.ac.uk) and the MRC Clinical Trials Unit at UCL. In India, the Sir Dorabji Tata Trust provides funding.
© Add-Aspirin, MRC CTU at UCL cookies